Cardioprotective effects of compound ALM-802 on subendocardial ischemia models

The investigation purpose. N1-(2,3,4-trimethoxybenzyl)-N2-{2-[(2,3,4-trimethoxybenzyl)amino]ethyl}-1,2-ethanediamine (ALM-802 compounds) cardioprotective effect has been studied in rat models of subendocardial ischemia caused by isoproterenol and dobutamine. Material and methods. Acute subendocardia...

Full description

Saved in:
Bibliographic Details
Main Authors: I. B. Tsorin, V. V. Barchukov, M. B. Vititnova, A. M. Likhosherstov, G. V. Mokrov, S. A. Kryzhanovskii
Format: Article
Language:Russian
Published: LLC “Publisher OKI” 2021-09-01
Series:Фармакокинетика и Фармакодинамика
Subjects:
Online Access:https://www.pharmacokinetica.ru/jour/article/view/268
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849248673066647552
author I. B. Tsorin
V. V. Barchukov
M. B. Vititnova
A. M. Likhosherstov
G. V. Mokrov
S. A. Kryzhanovskii
author_facet I. B. Tsorin
V. V. Barchukov
M. B. Vititnova
A. M. Likhosherstov
G. V. Mokrov
S. A. Kryzhanovskii
author_sort I. B. Tsorin
collection DOAJ
description The investigation purpose. N1-(2,3,4-trimethoxybenzyl)-N2-{2-[(2,3,4-trimethoxybenzyl)amino]ethyl}-1,2-ethanediamine (ALM-802 compounds) cardioprotective effect has been studied in rat models of subendocardial ischemia caused by isoproterenol and dobutamine. Material and methods. Acute subendocardial myocardial ischemia in anesthetized rats (urethane 1300 mg/kg, i.p.) was caused by infusion of isoproterenol (20 µg/kg/min i.v.) or dobutamine (80 µg/kg/min i.v.). Results. It was shown that in anesthetized rats, isoproterenol and dobutamine caused almost the same ST-segment depression in the II standard ECG lead. The compound ALM-802 (2 mg/kg i.v.), administered 2 minutes before the infusion start of isoproterenol or dobutamine, equally prevented the occurrence of ischemic changes on the ECG. Conclusion. The non-selective beta-adrenomimetic isoproterenol and the selective β1-adrenomimetic dobutamine cause subendocardial ischemia of the same intensity in anesthetized rats. The compound ALM-802 has a pronounced anti-ischemic effect on both models.
format Article
id doaj-art-affe1d8e2cb2471e92e89234a9ed47c6
institution Kabale University
issn 2587-7836
2686-8830
language Russian
publishDate 2021-09-01
publisher LLC “Publisher OKI”
record_format Article
series Фармакокинетика и Фармакодинамика
spelling doaj-art-affe1d8e2cb2471e92e89234a9ed47c62025-08-20T03:57:48ZrusLLC “Publisher OKI”Фармакокинетика и Фармакодинамика2587-78362686-88302021-09-0101182210.37489/2587-7836-2021-1-18-22263Cardioprotective effects of compound ALM-802 on subendocardial ischemia modelsI. B. Tsorin0V. V. Barchukov1M. B. Vititnova2A. M. Likhosherstov3G. V. Mokrov4S. A. Kryzhanovskii5FSBI “Zakusov Institute of Pharmacology”FSBI “Zakusov Institute of Pharmacology”FSBI “Zakusov Institute of Pharmacology”FSBI “Zakusov Institute of Pharmacology”FSBI “Zakusov Institute of Pharmacology”FSBI “Zakusov Institute of Pharmacology”The investigation purpose. N1-(2,3,4-trimethoxybenzyl)-N2-{2-[(2,3,4-trimethoxybenzyl)amino]ethyl}-1,2-ethanediamine (ALM-802 compounds) cardioprotective effect has been studied in rat models of subendocardial ischemia caused by isoproterenol and dobutamine. Material and methods. Acute subendocardial myocardial ischemia in anesthetized rats (urethane 1300 mg/kg, i.p.) was caused by infusion of isoproterenol (20 µg/kg/min i.v.) or dobutamine (80 µg/kg/min i.v.). Results. It was shown that in anesthetized rats, isoproterenol and dobutamine caused almost the same ST-segment depression in the II standard ECG lead. The compound ALM-802 (2 mg/kg i.v.), administered 2 minutes before the infusion start of isoproterenol or dobutamine, equally prevented the occurrence of ischemic changes on the ECG. Conclusion. The non-selective beta-adrenomimetic isoproterenol and the selective β1-adrenomimetic dobutamine cause subendocardial ischemia of the same intensity in anesthetized rats. The compound ALM-802 has a pronounced anti-ischemic effect on both models.https://www.pharmacokinetica.ru/jour/article/view/268subendocardial ischemiaisoproterenoldobutaminepfox inhibitorscompound alm-802
spellingShingle I. B. Tsorin
V. V. Barchukov
M. B. Vititnova
A. M. Likhosherstov
G. V. Mokrov
S. A. Kryzhanovskii
Cardioprotective effects of compound ALM-802 on subendocardial ischemia models
Фармакокинетика и Фармакодинамика
subendocardial ischemia
isoproterenol
dobutamine
pfox inhibitors
compound alm-802
title Cardioprotective effects of compound ALM-802 on subendocardial ischemia models
title_full Cardioprotective effects of compound ALM-802 on subendocardial ischemia models
title_fullStr Cardioprotective effects of compound ALM-802 on subendocardial ischemia models
title_full_unstemmed Cardioprotective effects of compound ALM-802 on subendocardial ischemia models
title_short Cardioprotective effects of compound ALM-802 on subendocardial ischemia models
title_sort cardioprotective effects of compound alm 802 on subendocardial ischemia models
topic subendocardial ischemia
isoproterenol
dobutamine
pfox inhibitors
compound alm-802
url https://www.pharmacokinetica.ru/jour/article/view/268
work_keys_str_mv AT ibtsorin cardioprotectiveeffectsofcompoundalm802onsubendocardialischemiamodels
AT vvbarchukov cardioprotectiveeffectsofcompoundalm802onsubendocardialischemiamodels
AT mbvititnova cardioprotectiveeffectsofcompoundalm802onsubendocardialischemiamodels
AT amlikhosherstov cardioprotectiveeffectsofcompoundalm802onsubendocardialischemiamodels
AT gvmokrov cardioprotectiveeffectsofcompoundalm802onsubendocardialischemiamodels
AT sakryzhanovskii cardioprotectiveeffectsofcompoundalm802onsubendocardialischemiamodels